| Better Care Home Health Inc | |
| 90 Main St Third Floor, Leominster, Massachusetts 1453 | |
| (978) 537-2273 | |
| Name | Better Care Home Health Inc |
|---|---|
| Location | 90 Main St Third Floor, Leominster, Massachusetts |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 227567 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 1420, 1430, 1432, 1436, 1440, 1453, 1462, 1463, 1464, 1468, 1469, 1475, 1510 |
| NPI Number | 1265791701 |
| Organization Name | BETTER CARE HOME HEALTH, INC |
| Address | 49 Pleasant St Ste A, Leominster, MA 01453 |
| Phone Number | 978-537-2273 |
News Archive
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the availability of Case Reviews Online, an online edition of Case Reviews print series offering radiology professionals self-assessment preparation for board review.
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis.
Viruses known to target the central nervous system may also affect neurons of the digestive tract, causing bowel dysfunction and abdominal pain.
› Verified 5 days ago
| Quality Rating: |
News Archive
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the availability of Case Reviews Online, an online edition of Case Reviews print series offering radiology professionals self-assessment preparation for board review.
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis.
Viruses known to target the central nervous system may also affect neurons of the digestive tract, causing bowel dysfunction and abdominal pain.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 92.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 95.1 | 98.6 |
| How often the home health team checked patients’ risk of falling | 98.6 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 78.7 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 71.1 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the availability of Case Reviews Online, an online edition of Case Reviews print series offering radiology professionals self-assessment preparation for board review.
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis.
Viruses known to target the central nervous system may also affect neurons of the digestive tract, causing bowel dysfunction and abdominal pain.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 72.3 | 79.6 |
| How often patients got better at getting in and out of bed | - | 81.1 |
| How often patients got better at bathing | 80.4 | 82.3 |
| How often patients’ breathing improved | 93.5 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 70 | 75 |
| How often home health patients had to be admitted to the hospital | - | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | - | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.8 | 94 |
News Archive
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the availability of Case Reviews Online, an online edition of Case Reviews print series offering radiology professionals self-assessment preparation for board review.
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis.
Viruses known to target the central nervous system may also affect neurons of the digestive tract, causing bowel dysfunction and abdominal pain.
› Verified 5 days ago
News Archive
Reata Pharmaceuticals, Inc. has announced that RTA 402 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer. RTA 402 is currently being studied in a Phase 1/2 trial in patients with pancreatic cancer, and is also in Phase 2 development for chronic kidney disease.
Advanced Cell Technology, Inc. announced today that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world. The decision removes the clinical hold that the FDA had placed on the trial.
Elsevier, the leading publisher of scientific, technical and medical information products and services, today announced the availability of Case Reviews Online, an online edition of Case Reviews print series offering radiology professionals self-assessment preparation for board review.
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis.
Viruses known to target the central nervous system may also affect neurons of the digestive tract, causing bowel dysfunction and abdominal pain.
› Verified 5 days ago
Health Alliance Home Health And Hospice Location: 60 Hospital Road, Leominster, Massachusetts 1453 Ratings: Phone: (978) 728-0621 | |
Ick-assurance Home Health Care Inc Location: 5 Park Street, Leominster, Massachusetts 1453 Ratings: NA Phone: (978) 342-0081 | |
Better Care Home Health Inc Location: 90 Main St Third Floor, Leominster, Massachusetts 1453 Ratings: Phone: (978) 537-2273 |